Compare Stocks › ABBV vs SLB

AbbVie Inc. (ABBV) vs SLB N.V. (SLB): Which Is the Better Buy in 2026?

As of 2026-11-01, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. SLB is undervalued at $54, with an intrinsic value of $155 and a margin of safety of 65%. Of the two, SLB has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
SLB
SLB N.V.
$53.74

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
SLB
  • ★SLB N.V. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★SLB N.V. scores 79/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • ★Free cash flow has grown at a 31.3% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
SLB
  • ⚠Gross margin of 16.6% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • ⚠Each dollar of retained earnings has produced only $0.14 of earning power — shareholders may have been better served by dividends.
  • ⚠Despite buyback spending, shares outstanding increased in 2 out of 3 years — stock-based compensation is offsetting repurchases.

Key Valuation Metrics

Learn more →
ABBV
SLB
Valuation
N/A
Free Cash Flow
$4.54B
N/A
FCF Yield
5.73%
50.67
Trailing P/E
26.09
18.24
Forward P/E
17.41
Quality & Moat
29.08%
ROIC
10.22%
N/A
ROE
11.66%
73.72%
Gross Margin
16.59%
0.60
PEG Ratio
1.50
Balance Sheet Safety
N/A
Net Debt / Equity
0.34
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
1.25
2.35%
Dividend Yield
2.20%
ABBV: 4Ties: 2SLB: 2
ABBVSLB

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

SLB

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
SLB
$-2.44
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$7.59B
Δ Market Cap
$-18.53B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
71.5% Overvalued
Price is 71.5% above estimated fair value
Current Price: $294.89
Fair Value: $172.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
SLB
61.8% Margin of Safety
Price is 61.8% below estimated fair value
Current Price: $53.74
Fair Value: $140.79
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

SLB

What growth rate is the market pricing in at $54?

+10.8%
Market-Implied Owner Earnings Growth
Standard FCF implies +7.3%

The market implies +10.8% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +7.3%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
SLB
79/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
SLB
-2.51
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
SLB
Insiders 0.2%Institutions 94.0%Retail & Other 5.8%
No. of Institutional Holders2,292
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
SLB
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
SLB
6
Sells (3M)
22
Sells (12M)
Total value (12M): $27.50M
GUILD HOWARD
Officer
$539,022
@ $53.65 · 2026-10-29
LE PEUCH OLIVIER
Chief Executive Officer
$1.33M
@ $53.17 · 2026-10-27
LE PEUCH OLIVIER
Chief Executive Officer
$2.10M
@ $60.00 · 2026-09-01
LE PEUCH OLIVIER
Chief Executive Officer
$300,000
@ $60.00 · 2026-08-31
LE PEUCH OLIVIER
Chief Executive Officer
$275,000
@ $55.00 · 2026-08-27
LE PEUCH OLIVIER
Chief Executive Officer
$1.31M
@ $52.55 · 2026-08-26
LE PEUCH OLIVIER
Chief Executive Officer
$1.42M
@ $56.99 · 2026-05-27
DE LA CHEVARDIERE PATRICK
Director
$108,660
@ $54.33 · 2026-05-07
GASSEN STEVE MATTHEW
Officer
$3.00M
@ $56.18 · 2026-05-01
LE PEUCH OLIVIER
Chief Executive Officer
$1.41M
@ $56.48 · 2026-04-29
DE LA CHEVARDIERE PATRICK
Director
$208,100
@ $52.02 · 2026-03-26
LE PEUCH OLIVIER
Chief Executive Officer
$1.26M
@ $50.56 · 2026-03-25
LE PEUCH OLIVIER
Chief Executive Officer
$1.30M
@ $52.00 · 2026-02-25
LE PEUCH OLIVIER
Chief Executive Officer
$1.26M
@ $50.40 · 2026-01-28
GUILD HOWARD
Officer
$659,420
@ $49.70 · 2026-01-26
DE LA CHEVARDIERE PATRICK
Director
$201,160
@ $50.29 · 2026-01-26
MERAD ABDELLAH
Officer
$2.98M
@ $49.70 · 2026-01-26
BIGUET STEPHANE
Chief Financial Officer
$3.03M
@ $49.70 · 2026-01-26
RALSTON DIANNE B
Officer
$921,542
@ $49.50 · 2026-01-26
COLEMAN PETER JOHN
Director
$197,010
@ $35.82 · 2025-11-26
BIGUET STEPHANE
Chief Financial Officer
$1.41M
@ $36.75 · 2025-11-13
MERAD ABDELLAH
Officer
$2.26M
@ $37.69 · 2025-11-11
RALSTON DIANNE B
Officer
$1.43M
@ $36.08 · 2025-09-12
DE LA CHEVARDIERE PATRICK
Director
$167,900
@ $33.58 · 2025-05-22
RAMAN APARNA
Officer
$1.06M
@ $42.28 · 2025-03-28
RENNICK GAVIN
Officer
$1.10M
@ $40.92 · 2025-02-26
RANDO BEJAR CARMEN
Officer
$223,252
@ $40.41 · 2025-01-31
MERAD ABDELLAH
Officer
$2.49M
@ $41.44 · 2025-01-29
AL MOGHARBEL KHALED
Officer
$5.43M
@ $44.09 · 2025-01-21
GUILD HOWARD
Officer
$595,228
@ $43.87 · 2025-01-21
PRECHNER UGO
Officer
$309,435
@ $44.20 · 2025-01-21
KASIBHATLA VIJAY
Officer
$1.10M
@ $43.94 · 2025-01-21
BIGUET STEPHANE
Chief Financial Officer
$1.97M
@ $43.87 · 2025-01-21
RALSTON DIANNE B
Officer
$1.90M
@ $43.96 · 2025-01-21
BIGUET STEPHANE
Chief Financial Officer
$512,294
@ $44.47 · 2024-11-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
SLB
FearGreed
😏Greed(62/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
SLB
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (62)
View ABBV Full AnalysisView SLB Full Analysis

Frequently Asked Questions: ABBV vs SLB

Is AbbVie Inc. or SLB N.V. more undervalued in 2026?▼

Based on our discounted cash flow model, SLB trades at a 65.2% margin of safety (intrinsic value $155 vs. price $54), compared to ABBV's -71.5% margin of safety (intrinsic $172 vs. $295).

Which stock has a wider economic moat, AbbVie Inc. or SLB N.V.?▼

ABBV scores 82/100 (Wide moat), while SLB scores 79/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?▼

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. SLB scores 2.8 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or SLB N.V.?▼

ABBV earns 29.1% ROIC versus SLB's 10.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or SLB N.V.'s?▼

SLB's dividend earns a safety score of 85/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). SLB has raised its dividend for 0 consecutive years.